Order Now For Fast Delivery!
This website uses cookies to enhance the user experience. Some cookies are essential for the use of the site. View our Privacy Policy and Cookie Policy for more information.
Terri Vidals
Terri Vidals
Telemedicine Buprenorphine: Expanding Access to Opioid Use Disorder Treatment
Telemedicine Buprenorphine: Expanding Access to Opioid Use Disorder Treatment
Tuesday 11th March 2025
Explore how telemedicine is changing opioid use disorder treatment with Dr. Stuart Gitlow and Terri Vidals.
40 minutes
Informative
Supportive
Compassionate
Educational
Non-judgmental
About this podcast
Author:
Terri Vidals
Overview:
For everyone in the healthcare industry looking to reduce substance abuse and drug diversion. The host, Terri Vidals, is a pharmacist with over 30 years of experience; fifteen of those years in medica...(view more)
Categories:
Innovative Treatments & Recovery Paths
Nutritional Pathways to Recovery
Family Recovery from Addiction
Navigating Intimate Relationships
Recovery Reimagined
Links:
Visit site
Episodes:
120 (View all)
Do you want to link to this podcast?
Get the buttons here!Telemedicine Buprenorphine: Expanding Access to Opioid Use Disorder Treatment
Episode Overview
- Telemedicine can expand access to buprenorphine for opioid use disorder.
- The Biden administration's new ruling allows audio-only visits for prescribing buprenorphine.
- Telehealth offers practical benefits by reducing patient churn due to logistical issues.
- Pharmacies play a crucial role in verifying prescriptions under the new regulation.
- Coordination between law enforcement and medical communities is essential to reduce stigma around addiction treatment.
Patients lie. And of course, we're aware that people aren't always forthcoming with us.
In this episode of 'Drug Diversion Insights with Terri Vidals', the focus is on the expanding access to opioid use disorder treatment through telemedicine. Host Terri Vidals, a seasoned pharmacist, sits down with Dr. Stuart Gitlow, a notable expert in addiction medicine, to discuss the Biden administration's new ruling that allows providers to prescribe buprenorphine via telehealth, including audio-only visits, without needing an initial in-person evaluation. Dr.
Gitlow shares his experiences and insights on how this ruling could change the landscape of addiction treatment. He reflects on the challenges and benefits of telemedicine, particularly during the COVID-19 pandemic, and addresses concerns about potential misuse of buprenorphine prescriptions. The episode also touches on the importance of maintaining a patient-doctor relationship and ensuring that the treatment provided is both effective and safe. Dr.
Gitlow's anecdotes about patient churn and the logistical issues faced by patients highlight the practical benefits of telemedicine in addiction treatment. The discussion also covers the role of pharmacies in verifying prescriptions and the need for better coordination between law enforcement and medical communities to reduce stigma around addiction treatment.
This episode is a must-listen for healthcare professionals looking to understand the implications of telemedicine in opioid use disorder treatment and for anyone interested in the evolving strategies to combat substance abuse.